Cargando…

Atomoxetine Effects on Executive Function as Measured by the BRIEF-A in Young Adults with ADHD: A Randomized, Double-Blind, Placebo-Controlled Study

OBJECTIVE: To evaluate the effect of atomoxetine treatment on executive functions in young adults with attention-deficit/hyperactivity disorder (ADHD). METHODS: In this Phase 4, multi-center, double-blind, placebo-controlled trial, young adults (18–30 years) with ADHD were randomized to receive atom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adler, Lenard A., Clemow, David B., Williams, David W., Durell, Todd M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141744/ https://www.ncbi.nlm.nih.gov/pubmed/25148243 http://dx.doi.org/10.1371/journal.pone.0104175

Ejemplares similares

Atomoxetine Increased Effect over Time in Adults with Attention‐Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double‐Blind, Placebo‐Controlled, Randomized Trials
por: Wietecha, Linda A., et al.
Publicado: (2016)

Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
por: Sumner, Calvin R, et al.
Publicado: (2009)

Efficacy of atomoxetine in adult attention-Deficit/Hyperactivity Disorder: a drug-placebo response curve analysis
por: Faraone, Stephen V, et al.
Publicado: (2005)

Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetine
por: Upadhyaya, Himanshu, et al.
Publicado: (2013)

A critical appraisal of atomoxetine in the management of ADHD
por: Childress, Ann C
Publicado: (2015)

Improving Executive Functioning in Children with ADHD: Training Multiple Executive Functions within the Context of a Computer Game. A Randomized Double-Blind Placebo Controlled Trial
por: Dovis, Sebastiaan, et al.
Publicado: (2015)

Influence of Atomoxetine on Relationship Between ADHD Symptoms and Prefrontal Cortex Activity During Task Execution in Adult Patients
por: Sugimoto, Atsunori, et al.
Publicado: (2021)

Atomoxetine: a novel treatment for child and adult ADHD
por: Ledbetter, Marcialee
Publicado: (2006)

Real‐World Dosing Patterns of Atomoxetine in Adults with Attention‐Deficit/Hyperactivity Disorder
por: Kabul, Samaneh, et al.
Publicado: (2015)

Clinical Impact of Not Achieving Recommended Dose on Duration of Atomoxetine Treatment in Adults with Attention‐Deficit/Hyperactivity Disorder
por: Clemow, David B., et al.
Publicado: (2016)

ADHD and EEG-neurofeedback: a double-blind randomized placebo-controlled feasibility study
por: Lansbergen, M. M., et al.
Publicado: (2010)

Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study
por: Adler, Lenard A, et al.
Publicado: (2013)

Atomoxetine treatment for nicotine withdrawal: a pilot double-blind, placebo-controlled, fixed-dose study in adult smokers
por: Silverstone, Peter H, et al.
Publicado: (2012)

Hot executive control and response to a stimulant in a double-blind randomized trial in children with ADHD
por: Yarmolovsky, Jessica, et al.
Publicado: (2016)

Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in Swedish children and adolescents
por: Svanborg, Pär, et al.
Publicado: (2009)

A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities
por: Clemow, David B, et al.
Publicado: (2017)

Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review
por: Treuer, Tamás, et al.
Publicado: (2016)

Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physicians
por: Dittmann, Ralf W, et al.
Publicado: (2009)

Effect of Atomoxetine on Hyperactivity in an Animal Model of Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Moon, Su Jin, et al.
Publicado: (2014)

Psychostimulants/Atomoxetine and Serious Cardiovascular Events in Children with ADHD or Autism Spectrum Disorder
por: Houghton, Richard, et al.
Publicado: (2019)

Atomoxetine as an Alternative Therapy for Adolescent Adhd With Comorbid Cerebral Palsy: A Case Report
por: Calilung, Dominique, et al.
Publicado: (2023)

Factors Associated With Initiation With Atomoxetine Versus Stimulants in the Treatment of Adults With ADHD: Retrospective Analysis of Administrative Claims Data
por: Van Brunt, David L., et al.
Publicado: (2006)

Treatment Response and Remission in a Double-Blind, Randomized, Head-to-Head Study of Lisdexamfetamine Dimesylate and Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder
por: Dittmann, Ralf W., et al.
Publicado: (2014)

Acute atomoxetine treatment of younger and older children with ADHD: A meta-analysis of tolerability and efficacy
por: Kratochvil, Christopher J, et al.
Publicado: (2008)

Acute neuropharmacological effects of atomoxetine on inhibitory control in ADHD children: A fNIRS study
por: Nagashima, Masako, et al.
Publicado: (2014)

A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder
por: Upadhyaya, Himanshu P., et al.
Publicado: (2013)

Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study
por: Dittmann, Ralf W., et al.
Publicado: (2013)

Atomoxetine Treatment Strengthens an Anti-Correlated Relationship between Functional Brain Networks in Medication-Naïve Adults with Attention-Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Clinical Trial
por: Lin, Hsiang-Yuan, et al.
Publicado: (2015)

Effect of Methylphenidate and Folic Acid on ADHD Symptoms and Quality of Life and Aggression: A Randomized Double Blind Placebo Controlled Clinical Trial
por: Ghanizadeh, Ahmad, et al.
Publicado: (2013)

The effect of atomoxetine on random and directed exploration in humans
por: Warren, Christopher M., et al.
Publicado: (2017)

Efficacy of Addition of Atomoxetine to Speech Therapy in Stuttering Severity of Children Aged 4-12 Years: A Double-Blind Randomized Controlled Trial
por: AHMADABADI, Farzad, et al.
Publicado: (2022)

Shared and Drug-Specific Effects of Atomoxetine and Methylphenidate on Inhibitory Brain Dysfunction in Medication-Naive ADHD Boys
por: Cubillo, Ana, et al.
Publicado: (2014)

The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review
por: Fu, Di, et al.
Publicado: (2022)

Single-dose effects of methylphenidate and atomoxetine on functional connectivity during an n-back task in boys with ADHD
por: Kowalczyk, Olivia S., et al.
Publicado: (2023)

Effect of Atomoxetine Treatment on Reading and Phonological Skills in Children with Dyslexia or Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia in a Randomized, Placebo-Controlled Trial
por: Shaywitz, Sally, et al.
Publicado: (2017)

Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling?
por: Fairman, Kathleen A., et al.
Publicado: (2018)

Pattern Classification of Working Memory Networks Reveals Differential Effects of Methylphenidate, Atomoxetine, and Placebo in Healthy Volunteers
por: Marquand, Andre F, et al.
Publicado: (2011)

Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate
por: Nagy, Peter, et al.
Publicado: (2015)

Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder: Results of 2 Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Trials
por: Adler, Lenard A., et al.
Publicado: (2022)

Effects of methylphenidate on the ERP amplitude in youth with ADHD: A double-blind placebo-controlled cross-over EEG study
por: Rubinson, Mica, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5hro4ouh8qj82rii3idposmk7o